MBX Biosciences, Inc. Loss At -$15.59 Mln In Q4

India, March 17 -- MBX Biosciences, Inc. (MBX) announced Loss for fourth quarter of -$15.59 million

The company's bottom line totaled -$15.59 million, or -$0.47 per share. This compares with -$8.84 million, or -$7.74 per share, last year.

MBX Biosciences, Inc. earnings at a glance (GAAP) :

-Earnings: -$15.59 Mln. vs. -$8.84 Mln. last year.-EPS: -$0.47 vs. -$7.74 last year.

For comments and feedback contact: [e-mail]

Published by HT Digital Content Services with permission from RTT News....